Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 7;14(7):e1002344.
doi: 10.1371/journal.pmed.1002344. eCollection 2017 Jul.

Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action

Teodora Wi  1 , Monica M Lahra  2   3 , Francis Ndowa  4 , Manju Bala  5 , Jo-Anne R Dillon  6 , Pilar Ramon-Pardo  7 , Sergey R Eremin  8 , Gail Bolan  9 , Magnus Unemo  10
Affiliations

Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action

Teodora Wi et al. PLoS Med. .

Abstract

In a Policy Forum, Teodora Wi and colleagues discuss the challenges of antimicrobial resistance in gonococci.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. The percentage (%) of isolates with decreased susceptibility or resistance to extended-spectrum cephalosporin (ESC) (cefixime and/or ceftriaxone) according to the most recent World Health Organization (WHO) Gonococcal Antimicrobial Surveillance Programme (GASP) data (2014 for most countries, but for a few countries, only 2011–2013 data were available).
Note: The areas in grey are disputed territories (e.g., Western Sahara, Jammu, and Kashmir), and no antimicrobial resistance (AMR) data are available from these regions.
Fig 2
Fig 2. The percentage (%) of isolates with resistance to azithromycin according to the most recent World Health Organization (WHO) Gonococcal Antimicrobial Surveillance Programme (GASP) data (2014 for most countries, but for a few countries, only 2011–2013 data were available).
Note: The areas in grey are disputed territories (e.g., Western Sahara, Jammu, and Kashmir), and no antimicrobial resistance (AMR) data are available from these regions.
Fig 3
Fig 3. The percentage (%) of isolates with resistance to ciprofloxacin according to the most recent World Health Organization (WHO) Gonococcal Antimicrobial Surveillance Programme (GASP) data (2014 for most countries, but for a few countries, only 2011–2013 data were available).
Note: The areas in grey are disputed territories (e.g., Western Sahara, Jammu, and Kashmir), and no antimicrobial resistance (AMR) data are available from these regions.
See this image and copyright information in PMC

References

    1. Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS ONE. 2015; 10(12):e0143304 doi: 10.1371/journal.pone.0143304 - DOI - PMC - PubMed
    1. Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al.; Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 386(9995):743–800. doi: 10.1016/S0140-6736(15)60692-4 - DOI - PMC - PubMed
    1. Murray CJ, Barber RM, Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah F, Abera SF, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: Quantifying the epidemiological transition. Lancet. 2015; 386(10009):2145–2191. doi: 10.1016/S0140-6736(15)61340-X - DOI - PMC - PubMed
    1. Cohen MS, Hoffman IF, Royce RA, Kazembe P, Dyer JR, Daly CC, et al.; AIDSCAP Malawi Research Group. Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1. Lancet. 1997; 349(9069):1868–1873. - PubMed
    1. World; Health Organization (WHO). Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae Geneva: WHO; 2012. Available from: http://www.who.int/reproductivehealth/publications/rtis/9789241503501/en/

Substances